Posts by Holly
MicrosensDx and ProteoGenix partner to advance novel biomarker test for sepsis
Latest news MicrosensDx and ProteoGenix partner to advance novel biomarker test for sepsis March 23, 2026 by MicrosensDx MicrosensDx is partnering with French biotech ProteoGenix to accelerate its diagnostic sepsis test towards important technical and clinical milestones. This strategic collaboration is allowing MicrosensDx to take advantage of ProteoGenix’s antibody expertise in the development of a…
Read MoreA promising solution to identify risk of sepsis
Latest news A promising solution to identify risk of sepsis September 11, 2024 by MicrosensDx MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test MicrosensDx is excited to announce that it is working with The Mayr Group at Imperial College London to develop a novel biomarker test for the early recognition of sepsis. Based…
Read More